All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-ZP216 | Human anti-Genome polyprotein T cell receptor (DD31), pCDTCR1 | Hepacivirus C | DD31 | Human | HSKKKCDEL | HLA B*0801 | Lentiviral vector | |
TCR-ZP217 | Human anti-Genome polyprotein T cell receptor (HCV1406), pCDTCR1 | Hepacivirus C | HCV1406 | Human | KLVALGINAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP218 | Human anti-Genome polyprotein T cell receptor (HAT-140pM), pCDTCR1 | Hepacivirus C | HAT-140pM | Human | ALRGMGVNAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP219 | Human anti-Genome polyprotein T cell receptor (HAT-2nM), pCDTCR1 | Hepacivirus C | HAT-2nM | Human | ALRGMGVNAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP220 | Human anti-Genome polyprotein T cell receptor (HAT-40pM), pCDTCR1 | Hepacivirus C | HAT-40pM | Human | ALRGMGVNAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP221 | anti-Genome polyprotein T cell receptor (), pCDTCR1 | Hepacivirus C | HSKKKCDEL | HLA-A*02:01 | Lentiviral vector | |||
TCR-ZP223 | Human anti-Genome polyprotein T cell receptor (BH8), pCDTCR1 | Hepacivirus C | BH8 | Human | KLVALGINAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP227 | anti-Genome polyprotein T cell receptor (NC10), pCDTCR1 | Hepacivirus C | NC10 | KLVALGINAV | HLA-A*02:01 | Lentiviral vector | ||
TCR-ZP228 | Human anti-Genome polyprotein T cell receptor (UF3), pCDTCR1 | Hepacivirus C | UF3 | Human | KLVALGINAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP229 | Human anti-Genome polyprotein T cell receptor (P1299_1098), pCDTCR1 | Yellow fever virus | P1299_1098 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP230 | Human anti-Genome polyprotein T cell receptor (P1299_1100), pCDTCR1 | Yellow fever virus | P1299_1100 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP231 | Human anti-Genome polyprotein T cell receptor (P1299_1104), pCDTCR1 | Yellow fever virus | P1299_1104 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP232 | Human anti-Genome polyprotein T cell receptor (P1299_1116), pCDTCR1 | Yellow fever virus | P1299_1116 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP233 | Human anti-Genome polyprotein T cell receptor (P1299_1121), pCDTCR1 | Yellow fever virus | P1299_1121 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP234 | Human anti-Genome polyprotein T cell receptor (P1299_1125), pCDTCR1 | Yellow fever virus | P1299_1125 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP235 | Human anti-Genome polyprotein T cell receptor (P1299_1130), pCDTCR1 | Yellow fever virus | P1299_1130 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP236 | Human anti-Genome polyprotein T cell receptor (P1299_1133), pCDTCR1 | Yellow fever virus | P1299_1133 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP237 | Human anti-Genome polyprotein T cell receptor (P1299_1134), pCDTCR1 | Yellow fever virus | P1299_1134 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP238 | Human anti-Genome polyprotein T cell receptor (P1299_1135), pCDTCR1 | Yellow fever virus | P1299_1135 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector | |
TCR-ZP239 | Human anti-Genome polyprotein T cell receptor (P1299_1136), pCDTCR1 | Yellow fever virus | P1299_1136 | Human | LLWNGPMAV | HLA-A*02:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION